The importance of cellular immune response to HIV: implications for antibody production and vaccine design by Brenna, E, McMichael, AJ

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay by Walters, LC, McMichael, AJ, Gillespie, GM

Discovery of HLA-E-presented epitopes: MHC-E/Peptide binding and t-cell recognition by Ruibal, P, Franken, KLMC, van Meijgaarden, KE, Walters, LC, McMichael, AJ, Gillespie, GM, Joosten, SA, Ottenhoff, THM

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation by Huisman, BD, Guan, N, Rückert, T, Garner, L, Singh, NK, McMichael, AJ, Gillespie, GM, Romagnani, C, Birnbaum, ME

Intracellular trafficking of HLA-E and its regulation by He, W, Gea-Mallorqui, E, Colin-York, H, Fritzsche, M, Gillespie, GM, Brackenridge, S, Borrow, P, McMichael, AJ

Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity by Mendoza, JL, Fischer, S, Gee, MH, Lam, LH, Brackenridge, S, Powrie, FM, Birnbaum, M, McMichael, AJ, Garcia, KC, Gillespie, GM

Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes by Walters, LC, Rozbesky, D, Harlos, K, Quastel, M, Sun, H, Springer, S, Rambo, RP, Mohammed, F, Jones, EY, McMichael, AJ, Gillespie, GM

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies by Haynes, BF, Wiehe, K, Borrow, P, Saunders, KO, Korber, B, Wagh, K, McMichael, AJ, Kelsoe, G, Hahn, BH, Alt, F, Shaw, GM

Comparison of neutralizing antibody responses elicited from highly diverse polyvalent heterotrimeric HIV-1 gp140 cocktail immunogens versus a monovalent counterpart in rhesus macaq... by Bowles, EJ, Schiffner, T, Rosario, M, Needham, GA, Ramaswamy, M, McGouran, J, Kessler, B, LaBranche, C, McMichael, AJ, Montefiori, D, Sattentau, QJ, Hanke, T, Stewart-Jones, GBE

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial by Campion, SL, Brenna, E, Thomson, E, Fischer, W, Ladell, K, McLaren, JE, Price, DA, Frahm, N, McElrath, JM, Cohen, KW, Maenza, JR, Walsh, SR, Baden, LR, Haynes, BF, Korber, B, Borrow, P, McMichael, AJ

HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities by Yang, H, Rei, M, Brackenridge, S, Brenna, E, Sun, H, Abdulhaqq, S, Liu, MKP, Ma, W, Kurupati, P, Xu, X, Cerundolo, V, Jenkins, E, Davis, SJ, Sacha, JB, Früh, K, Picker, LJ, Borrow, P, Gillespie, GM, McMichael, AJ

Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides by Yang, X, Garner, LI, Zvyagin, IV, Paley, MA, Komech, EA, Jude, KM, Zhao, X, Fernandes, RA, Hassman, LM, Paley, GL, Savvides, CS, Brackenridge, S, Quastel, MN, Chudakov, DM, Bowness, P, Yokoyama, WM, McMichael, AJ, Gillespie, GM, Garcia, KC

HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses by Lin, Z, Bashirova, AA, Viard, M, Garner, L, Quastel, M, Beiersdorfer, M, Kasprzak, WK, Akdag, M, Yuki, Y, Ojeda, P, Das, S, Andresson, T, Naranbhai, V, Horowitz, A, McMichael, AJ, Hoelzemer, A, Gillespie, GM, Garcia-Beltran, WF, Carrington, M

Temporal dynamics of CD8+ T cell effector responses during primary HIV infection. by Demers, KR, Makedonas, G, Buggert, M, Eller, MA, Ratcliffe, SJ, Goonetilleke, N, Li, CK, Eller, LA, Rono, K, Maganga, L, Nitayaphan, S, Kibuuka, H, Routy, J-P, Slifka, MK, Haynes, BF, McMichael, AJ, Bernard, NF, Robb, ML, Betts, MR

Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding. by Walters, LC, Harlos, K, Brackenridge, S, Rozbesky, D, Barrett, JR, Jain, V, Walter, TS, O'Callaghan, CA, Borrow, P, Toebes, M, Hansen, SG, Sacha, JB, Abdulhaqq, S, Greene, JM, Früh, K, Marshall, E, Picker, LJ, Jones, EY, McMichael, AJ, Gillespie, GM

The role of MHC-E in T Cell immunity is conserved among humans, rhesus macaques, and cynomolgus macaques by Wu, HL, Wiseman, RW, Hughes, CM, Webb, GM, Abdulhaqq, SA, Bimber, BN, Hammond, KB, Reed, JS, Gao, L, Burwitz, BJ, Greene, JM, Ferrer, F, Legasse, AW, Axthelm, MK, Park, BS, Brackenridge, S, Maness, NJ, McMichael, AJ, Picker, LJ, O'Connor, DH, Hansen, SG, Sacha, JB

HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation by Yang, H, Sun, H, Brackenridge, S, Zhuang, X, Wing, PAC, Quastel, M, Walters, L, Garner, L, Wang, B, Yao, X, Felce, SL, Peng, Y, Moore, S, Peeters, BWA, Rei, M, Canto Gomes, J, Tomas, A, Davidson, A, Semple, MG, Turtle, LCW, Openshaw, PJM, Baillie, JK, Mentzer, AJ, Klenerman, P, ISARIC4C Investigators, Borrow, P, Dong, T, McKeating, JA, Gillespie, GM, McMichael, AJ

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease by Peng, Y, Felce, SL, Dong, D, Penkava, F, Mentzer, AJ, Yao, X, Liu, G, Yin, Z, Chen, J-L, Lu, Y, Wellington, D, Wing, PAC, Dominey-Foy, DCC, Jin, C, Wang, W, Hamid, MA, Fernandes, RA, Wang, B, Fries, A, Zhuang, X, Ashley, N, Rostron, T, Waugh, C, Sopp, P, Hublitz, P, Beveridge, R, Tan, TK, Dold, C, Kwok, AJ, Rich-Griffin, C, Dejnirattisa, W, Liu, C, Kurupati, P, Nassiri, I, Watson, RA, Tong, O, Taylor, CA, Kumar Sharma, P, Sun, B, Curion, F, Revale, S, Garner, LC, Jansen, K, Ferreira, RC, Attar, M, Fry, JW, Russell, RA, Stauss, HJ, James, W, Townsend, A, Ho, L-P, Klenerman , P, Mongkolsapaya , P, Screaton, GR, Dendrou, C, Sansom , SN, Bashford-Rogers, R, Chain , B, Smith , GL, McKeating, JA, Fairfax, BP, Bowness , P, McMichael, AJ, Ogg, G, Knight, JC, Dong, T